A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

NCT02233803 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler
DRUG: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler
DRUG: NEUMOTEX 400 (Budesonide 400 mcg)
DRUG: Salbutamol 100 mcg pMDI

Sponsor

GlaxoSmithKline